Viyash Scientific (NSE:VIYASH) Common Stock: ₹874 Mil (As of Mar. 2026)


NSE:VIYASH Viyash Scientific Ltd NSE:VIYASH
76 GF Score
Price ₹277.80
GF Value ₹172.17
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Viyash Scientific Common Stock?

Viyash Scientific NSE:VIYASH -1.16% 76 Common Stock is ₹874 Mil as of Mar. 2026. GuruFocus rates NSE:VIYASH with a GF Score™ of 76/100 and a GF Value™ of ₹172.17 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Viyash Scientific's quarterly common stock declined from Sep. 2025 (₹503 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹874 Mil).

Viyash Scientific's annual common stock increased from Mar. 2024 (₹499 Mil) to Mar. 2025 (₹501 Mil) and increased from Mar. 2025 (₹501 Mil) to Mar. 2026 (₹874 Mil).

Viyash Scientific Common Stock Historical Data

* Premium members only.

The historical data trend for Viyash Scientific's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viyash Scientific Common Stock Chart

Viyash Scientific Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 496.74 498.86 498.86 500.60 873.70

Viyash Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 500.60 0.00 503.30 0.00 873.70
NSE:VIYASH
76GF Score
Viyash Scientific Ltd NSE:VIYASH
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viyash Scientific Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹874 Mil mean?
Viyash Scientific (NSE:VIYASH) has a Common Stock of ₹874 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Viyash Scientific and its competitors.
Is Viyash Scientific's Common Stock too high?
Viyash Scientific's current Common Stock is ₹874 Mil. Overall, Viyash Scientific has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viyash Scientific's Common Stock compare to ZTS and UTHR?
Viyash Scientific's Common Stock of ₹874 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Viyash Scientific and its competitors. Viyash Scientific's current Common Stock is ₹874 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viyash Scientific stock overvalued right now?
Based on GuruFocus' analysis, Viyash Scientific (NSE:VIYASH) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹172.17, compared to a current price of ₹277.80 — trading 61.4% above its estimated fair value. The current Common Stock is ₹874 Mil. Viyash Scientific's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Viyash Scientific (NSE:VIYASH), the current Common Stock is ₹874 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viyash Scientific (NSE:VIYASH) Overvalued in 2026?

Based on GuruFocus' analysis, Viyash Scientific stock appears to be overvalued. The current stock price of ₹277.80 is trading 61.4% above its estimated GF Value™ of ₹172.17. GuruFocus considers Viyash Scientific to be Significantly Overvalued.

Key valuation signals for NSE:VIYASH:

  • Common Stock: ₹874 Mil
  • GF Value™: ₹172.17 vs. price of ₹277.80 (61.4% above fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the NSE:VIYASH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viyash Scientific Business Description

Other Exchanges 512529:India
Address Road No.6, Kakatiya Hills, 3rd Floor, Srivalli’s Corporate, Plot No. 290, Guttala Begumpet, Jubilee Hills, Madhapur, Survey number 33 34P to 39, Hyderabad, KA, IND, 500033
Viyash Scientific Ltd is a pharmaceutical company with activities spanning formulations, active pharmaceutical ingredients (APIs), and intermediates. It is focused on research and development infrastructure for APIs and formulations. Its product portfolio spans several therapeutic areas, including ARV, cardiovascular, central nervous system, analgesics, antibiotics, antihistamines, diabetes, gastrointestinal, anticoagulants, and oncology.
76GF Score

Get the complete analysis for NSE:VIYASH

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹277.80
Price
₹172.17
GF Value